SEARCH

SEARCH BY CITATION

References

  • 1
    Dent J. Gastro-oesophageal reflux disease. Digestion 1998; 59: 43345.
  • 2
    Robinson M. Medical management of gastroesophageal reflux disease. In: CastellDO, RichterJE, eds. The Esophagus, 3rd edn. Philadelphia: Lippincott Williams & Wilkins, 1999: 44762.
  • 3
    Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997; 112: 1798810.
  • 4
    Gardner JD, Rodriguez-Stanley S, Robinson M. Integrated acidity and the pathophysiology of GERD. Am J Gastroenterol 2001; 96: 136370.
    Direct Link:
  • 5
    Robertson D, Aldersley M, Shepherd H, Smith CL. Patterns of acid reflux in complicated oesophagitis. Gut 1987; 28: 14848.
  • 6
    Carlsson R, Dent J, Watts R, et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. Eur J Gastroenterol Hepatol 1998; 10: 11924.
  • 7
    Gardner JD, Perdomo C, Sloan S, et al. Integrated acidity and rabeprazole pharmacology. Aliment Pharmacol Ther 2002; 16: 45564.
  • 8
    Gardner JD, Sloan S, Miner PB Jr, Robinson M. Determination of the reduction in gastric acidity necessary to prevent pathologic oesophageal reflux in GERD patients treated with a proton pump inhibitor. Aliment Pharmacol Ther 2003; 17: 95564.
  • 9
    Gardner JD, Sloan S, Miner PB Jr, Robinson M. Meal-stimulated gastric acid secretion and integrated gastric acidity in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003; 17: 94553.
  • 10
    Hetzel DJ, Dent J, Reed WD, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988; 95: 90312.
  • 11
    Swets JA. Measuring the accuracy of diagnostic systems. Science 1988; 240: 128593.
  • 12
    McNeil BJ, Keeler E, Adelstein SJ. Primer on certain elements of medical decision making. N Engl J Med 1975; 293: 2115.
  • 13
    Hanley JA, McNeil BJ. A method of comparing the areas under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 2936.
  • 14
    Hanley JA, McNeil BJ. The meaning and use of the area under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 83943.
  • 15
    Gardner JD, Sloan S, Robinson M, Miner PB Jr. Heartburn severity can predict pathologic oesophageal reflux in GERD patients treated with a proton pump inhibitor. Aliment Pharmacol Ther 2003; 18: 13340.
  • 16
    Motulsky H. Interpreting laboratory tests: introduction to Bayesian thinking. In:Intuitive Biostatistics. New York: Oxford University Press, 1995: 12939.
  • 17
    Hoffrage U, Lindsey S, Hertwig R, Gigerenzer G. Communicating statistical information. Science 2000; 290: 22612.
  • 18
    Schindlbeck NE, Heinrich C, Konig A, Dendorfer A, Pace F, Muller-Lissner SA. Optimal thresholds, sensitivity, and specificity of long-term pH-metry for detection of gastroesophageal reflux disease. Gastroenterology 1987; 93: 8590.
  • 19
    Jamieson JR, Stein HJ, DeMeester TR, et al. Ambulatory 24-h esophageal monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 1992; 87: 110211.
  • 20
    Hurlimann S, Abbuhl B, Inauen W, Halter F. Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole. Aliment Pharmacol Ther 1994; 8: 193201.
  • 21
    Hedenstrom H, Alm C, Kraft M, Grahnen A. Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers. Aliment Pharmacol Ther 1997; 11: 113741.
  • 22
    Hatlebakk JG, Berstad A. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease. Clin Pharmacokinet 1996; 31: 386406.
  • 23
    Gardner JD, Ciociola AA, Robinson M. Measurement of meal-stimulated gastric acid secretion by in vivo gastric autotitration. J Appl Physiol 2002; 92: 42734.
  • 24
    Holloway RH, Bryant W, Dent J. Failure of transient lower oesophageal sphincter relaxation in response to gastric distension in patients with achalasia: evidence for neural mediation of transient lower oesophageal sphincter relaxations. Gut 1989; 30: 7627.
  • 25
    Holloway RH, Koeyan P, Dent J. Provocation of transient lower esophageal sphincter relaxation by meals with symptomatic gastroesophageal reflux. Dig Dis Sci 1991; 36: 10349.
  • 26
    Boulant J, Mathieu S, D'Amato M, Abergel A, Dapoigny M, Bommelaer G. Cholecystokinin in transient lower esophageal sphincter relaxation due to gastric distension in humans. Gut 1997; 40: 57581.
  • 27
    Boeckxstaens GE, Hirsch DP, Fakhry N, Holloway RH, D'Amato M, Tytgat GNJ. Involvement of cholecystokininA receptors in transient lower esophageal sphincter relaxation triggered by gastric distension. Am J Gastroenterol 1998; 93: 18238.
    Direct Link:
  • 28
    Clave P, Gonzalez A, Moreno A, et al. Endogenous cholecystokinin enhances postprandial gastroesophageal reflux in humans through extrasphincteric receptors. Gastroenterology 1998; 115: 597604.
  • 29
    Hirsch DP, Holloway RH, Tytgat GN, Boeckstaens GE. Involvement of nitric oxide in human transient lower esophageal sphincter relaxations and esophageal primary peristalsis. Gastroenterology 1998; 115: 137480.
  • 30
    Zerbib F, Bruley Des Varannes S, Scarpignato C, Leray V, D'Amato M, Roze C. Endogenous cholecystokinin in postprandial esophageal sphincter function and fundic tone in humans. Am J Physiol 1998; 275: G126673.